These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8471431

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Hill BT.
    Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
    [Abstract] [Full Text] [Related]

  • 6. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T, Masuda H, Naito M, Tamai H.
    Anticancer Res; 2001 Jul; 21(4A):2463-9. PubMed ID: 11724308
    [Abstract] [Full Text] [Related]

  • 7. Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity.
    Taverna P, Hansson J, Scanlon KJ, Hill BT.
    Carcinogenesis; 1994 Sep; 15(9):2053-6. PubMed ID: 7923602
    [Abstract] [Full Text] [Related]

  • 8. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
    Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL, Chaney SG.
    Cancer Res; 1994 Jul 01; 54(13):3500-5. PubMed ID: 8012973
    [Abstract] [Full Text] [Related]

  • 9. Detection of proteins that recognize platinum-modified DNA using gel mobility shift assay.
    Fujiwara Y, Kasahara K, Sugimoto Y, Nishio K, Ohmori T, Saijo N.
    Jpn J Cancer Res; 1990 Dec 01; 81(12):1210-3. PubMed ID: 2125989
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
    Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T.
    Clin Cancer Res; 1996 Feb 01; 2(2):427-32. PubMed ID: 9816187
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DNA binding activities of p53 protein following cisplatin damage of ovarian cells.
    Wetzel CC, Berberich SJ.
    Oncol Res; 1998 Feb 01; 10(3):151-61. PubMed ID: 9700726
    [Abstract] [Full Text] [Related]

  • 18. Localization of the binding region of high mobility group protein 2 to cisplatin-damaged DNA.
    Lawrence DL, Engelsberg BN, Farid RS, Hughes EN, Billings PC.
    J Biol Chem; 1993 Nov 15; 268(32):23940-5. PubMed ID: 8226934
    [Abstract] [Full Text] [Related]

  • 19. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.
    Li QQ, Yunmbam MK, Zhong X, Yu JJ, Mimnaugh EG, Neckers L, Reed E.
    Cell Mol Biol (Noisy-le-grand); 2001 Nov 15; 47 Online Pub():OL61-72. PubMed ID: 11936875
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
    Hill BT, Shellard SA, Hosking LK, Dempke WC, Fichtinger-Schepman AM, Tone T, Scanlon KJ, Whelan RD.
    Cancer Res; 1992 Jun 01; 52(11):3110-8. PubMed ID: 1591724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.